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Abstract 
Peritoneal washing cytology (PWC) is a useful indicator of ovarian surface 
involvement and peritoneal dissemination by ovarian tumours. It may identify 
subclinical peritoneal spread and thus provide valuable staging and prognostic 
information, particularly for non-serous ovarian tumours. The role of PWC as 
a prognostic indicator for endometrial carcinoma is less clear, due in part to 
the questionable significance of identifying endometrial tumour cells in the 
peritoneum. 
Detection of metastatic carcinoma in PWC is based on recognition of non-
mesothelial cell characteristics, however a number of conditions such as 
reactive mesothelial cells, endometriosis and endosalpingiosis may mimic this 
appearance. Cells from these conditions may have a similar presentation in 
PWC to that of serous borderline tumours and low grade serous carcinoma. 
The presence of cilia, lack of single atypical cells, prominent cytoplasmic 
vacuolation, marked nuclear atypia or two distinct cell populations are features 
favouring a benign process. Attention to these features along with close 
correlation with clinical history and the results of surgical pathology should 
help avoid errors. Additional assistance may be provided by the use of cell 
blocks and special stains. 
 
Keywords: Peritoneal Washing, Peritoneum, Cytology, Gynaecological 
Malignancy, Immunocytochemistry
3 
 
Introduction 
Peritoneal dissemination by gynaecological malignancies, particularly ovarian 
tumours, often manifests in malignant ascites. Microscopic peritoneal seeding 
with tumour cells predates the formation of ascites and its detection by 
peritoneal washing cytology (PWC) may provide valuable staging and 
prognostic information. Identification of patients with occult (microscopic) 
peritoneal dissemination may be useful in defining a group of patients that 
would benefit from different treatment. The technique of intraoperative 
peritoneal washing cytology was introduced in 1956 by Keetle and Elkin 1. In 
1975 the International Federation of Gynecologists & Obstetricians (FIGO) 
incorporated results of PWC into the staging classification for ovarian 
carcinoma and in 1989 for endometrial carcinoma. The technique may also be 
useful in identifying recurrent or persistent cancer and has been applied to a 
variety of non-gynaecological cancers.  
 
This review discusses the role of PWC and its morphological interpretation for 
the most common malignancies encountered. Pitfalls in diagnosis and 
adjunctive techniques are also reviewed. 
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Preparation and Specimen Adequacy  
Specimen adequacy in PWC is poorly defined. DeMay2 points out that the 
majority of published series contain no cases reported as unsatisfactory while a 
few have   surprisingly high rates. Low cellularity may be a cause of false 
negative results 3. 
 
Peritoneal washing specimens are frequently heavily contaminated with blood 
and methods to concentrate diagnostic cells are essential.  Several methods, 
including Carnoy’s fixation and gradient density centrifugation have been 
reported. Mulvaney4 used Ficoll gradient density centrifugation to achieve this 
and reported only 1.5% (9/613) of specimens inadequate for interpretation.  
 
In our laboratory we find blood removal is almost always required for PW 
specimens. Specimens are centrifuged, the supernatant discarded and two 
direct smears are prepared. One is fixed in 95% alcohol for Pap staining and 
the other air-dried for rapid Giemsa staining.  If the specimen is bloody, the 
remaining pellet is then resuspended in a Hanks/methanol solution (HMS: 1 
part methanol; 2 parts Hank’s balanced salt solution; 3 parts distilled water) 
and agitated for 10 minutes. This step is highly effective at lysing the red 
blood cells without significantly altering cellular arrangements or morphology. 
The solution is then centrifuged again and if a pellet is visible then a direct 
smear is prepared and alcohol fixed. If only a scanty pellet remains, the 
material is processed as a cytospin for Pap staining. This processing allows 
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evaluation of the specimen in its ‘native’ state as well as concentrating 
diagnostic cells from a large proportion of the submitted sample. In our 
experience it results in a very low proportion of specimens reported as ‘blood 
only’. 
 
Applications 
Although positive PWC is useful for documenting the presence of malignant 
cells in the peritoneum, this is not always of prognostic significance. Positive 
PWC is generally seen in patients with a poor prognosis, however for some 
primary sites this is not an independent factor, but rather is associated with 
other prognostic indicators such as lymph node involvement and deep stromal 
invasion. Additionally, not all free cancer cells in the peritoneum survive and 
establish intraperitoneal metastases.  
 
Benign Findings 
Peritoneal washing specimens are generally highly cellular with mesothelial 
cells arranged in monolayered sheets. The cells are regularly spaced with a 
moderate amount of cytoplasm, usually forming pavement-like sheets (Figure 
1). Nuclei may vary considerably in size from sheet to sheet but are usually 
locally uniform with fine, even chromatin and small nucleoli (Figure 2). 
Nuclear longitudinal grooves and sometimes-folded nuclear membranes may 
be seen (Figure 3). The latter are said to be more common in mid-cycle2. The 
most common pattern is numerous, sometimes quite large, sheets of 
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mesothelial cells with minimal leucocytes and single cells. Variations on this 
pattern include increased numbers of single cells, including macrophages, 
leucocytes and mesothelial cells, and, in reactive conditions, the presence of 
smaller, rounded groups with greater depth of focus.  
 
Other benign findings include skeletal muscle fragments and collagen balls. 
So-called collagen balls (Figure 4) are spheroids of collagen surrounded by a 
single layer of mesothelial cells5. In Papanicolaou stained preparations they 
appear as distinctive aqua coloured balls of homogenous material. By focusing 
through the ball it is possible to identify its rounded nature and the single layer 
of mesothelial cells with bland nuclei. Examination of surgical specimens 
suggests that collagen balls originate from minute papillary stromal projections 
on the surface of the ovary that are covered with mesothelium5. Wojcik and 
Naylor5 reported finding collagen balls in 4.5% of 418 peritoneal washing 
specimens. In our experience they are seen much more frequently. Review of 
80 consecutive specimens identified collagen in balls in 48%, occurring in 
almost half of both benign and malignant specimens. This higher frequency 
may be the result of the thorough sampling of the specimen provided by our 
preparation method. Although they are listed as a possible cause for false 
positive diagnoses by some authors5,6, collagen balls are usually an easily 
recognised incidental benign finding. 
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Benign Gynaecological Disease 
Although PWC may identify occult carcinoma during surgery for benign 
disease the incidence of this is very low. Several large series have failed to 
find any cases with positive PWC amongst patients with benign 
gynaecological disease 7,8,9.   
 
Ovarian Tumours 
For ovarian tumours positive PWC is a sensitive indicator of ovarian surface 
involvement and peritoneal dissemination and will detect a high proportion of 
patients with subclinical intraperitoneal extension10. The technique provides 
wider sampling of the peritoneum than random staging biopsies. Several 
authors have reported positive PWC in cases of ovarian borderline tumours of 
low malignant potential (LMP) without other evidence of peritoneal implants 
or ovarian surface involvement4,10.  
 
Peritoneal washing cytology plays a valuable role in the staging of ovarian 
tumours. Four year survival of patients with ovarian carcinoma has been 
shown to be significantly different depending on PWC regardless of other 
parameters11. Mulvaney4  reported 63% (5/8) of borderline ovarian tumours 
and 50% (3/6) of non-serous ovarian malignancies were upstaged as a result of 
PWC results. However for serous carcinomas, only 7% (1/14) were upstaged 
on PWC, probably due to the clinically obvious dissemination of tumours on 
presentation. 
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Morphologically, ovarian epithelial tumours show a spectrum from benign 
cystadenomas through low malignant potential (borderline) tumours to 
malignant adenocarcinomas. Borderline tumours constitute about 10-15% of 
serous tumours and histologically show epithelial proliferation with 
stratification and tufting but lack destructive stromal invasion. About a third 
are associated with peritoneal implants, both invasive and non-invasive12. 
Borderline tumours have a better prognosis and generally are managed more 
conservatively and their distinction from low grade adenocarcinomas in PW 
specimens may therefore be important.  
 
Borderline tumours tend to present in PW specimens as large, smooth 
bordered, papillary fragments composed of small uniform cells with high N/C 
ratio and inconspicuous nucleoli (Figure 5). Mitotic figures and cytoplasmic 
vacuoles are infrequent. Psammoma bodies may be seen in the PWC of half to 
two thirds of cases4,13,14,15.   
 
By contrast, the PWC of invasive ovarian carcinoma is characterised by 
smaller, less cohesive papillary fragments of cells with irregular borders. 
Individual cells are relatively larger and more pleomorphic with a low N/C 
ratio and abundant cytoplasmic vacuoles (Figure 6). In general PWC 
preparations are more cellular than seen in borderline tumours with frequent 
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single cells and mitoses. Adenocarcinomas are also more likely to be 
anueploid14. 
 
Although these general morphological differences exist and some studies have 
suggested that a distinction between borderline serous tumours and frank 
adenocarcinomas is possible15, most studies of low grade carcinoma have 
concluded that in practice it is not possible to separate them from ovarian LMP 
tumours in PWC due to the overlap in features10,12,14,16. Correlation with 
histology results from surgical specimens is therefore an essential step. 
 
Cytological typing of ovarian tumours is not usually required, as surgical 
specimens provide more reliable classification. Serous, mucinous and 
endometrioid tumours all generally show typical cytological features of 
adenocarcinoma. Although some features are more commonly expressed in 
certain tumours, such as psammoma bodies in serous tumours and mucin in 
mucinous tumours, there are no specific features17. Clear cell carcinomas are 
somewhat distinctive cytologically, usually showing single cells and sheets of 
cells with abundant finely vacuolated cytoplasm and round nuclei with 
prominent nucleoli (Figure 7). The cells may form small to medium-sized, 
rounded groups of cells surrounding metachromatic interluminal  material4,16. 
In mixed Mullerian tumours it is usually the epidermal component that is 
present in PWC specimens. Germ cell tumours are usually easily recognised as 
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malignant, although some, such as yolk sac tumours, may closely resemble 
adenocarcinoma18. 
 
Endometrial Tumours 
Unlike ovarian carcinoma, the role of PWC for endometrial carcinoma is not 
as clear cut.  There is a significant increase in the incidence of abnormal PW in 
advanced stage disease (about 30% positive for stage III/IV compared with 
around 10% for stage I). However in advanced disease positive PWC may 
simply be a manifestation of extrauterine spread rather than an independent 
poor prognostic factor. It is in cases of early stage (I) disease where positive 
PWC could be of most prognostic importance. Unfortunately for Stage I 
endometrial carcinoma there are inconsistent results reported. Some series 
have shown significantly better survival rates if PWC is negative1,19,20,21,22, 
however others have found no correlation of other histological parameters with 
positive PWC or with poorer survival23,24. Yet again, some series have 
reported correlation of positive PWC with some histological parameters but 
not with outcome25,26,27. These studies found PWC to be correlated with depth 
myometrial invasion, histological grade, cervical involvement and vascular 
channel involvement but not histologic subtypes, grade, adnexal or lymph 
node involvement.  
 
In part this lack of clear-cut significance may be related to the mode of tumour 
cell spread from endometrial tumours to the peritoneum and to the variable 
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implications of tumour cells in the peritoneum. In the case of endometrial 
cancer, malignant cells identified in the peritoneum may not necessarily equal 
established metastatic disease.  
 
The methods by which malignant cells reach the peritoneum is also of interest. 
In early stage disease where the tumour is otherwise confined to the uterus, the 
fallopian tube represents the most likely conduit. Menczer et al28 reported 
positive tubal cytology in 22% of patients with endometrial carcinoma of all 
stages but positive PWC in only 8.5%. Seventy-five percent of patients with 
positive PWC had negative tubal cytology. In a study of fallopian tube 
washings, Mulvaney et al4 found  positive fallopian tube cytology with 
positive PWC in  72%. Metastasis via the lymphatics and haematogenous 
spread account for some peritoneal seeding as evidenced by cases of 
endometrial carcinoma with a history of BSO that develop positive PWC29. 
Lymphatic spread, as well as release of tumour cells from areas of serosal 
invasion has also been proposed as a method of peritoneal spread for gastric30 
and pancreatic cancer31. However, although some studies have found a 
correlation between positive PWC and vascular invasion for endometrial 
cancer26,32, others have not27. Transtubal retrograde dissemination, for example 
during hysteroscopy, may be responsible for the presence of malignant cells in 
some cases of early stage endometrial carcinoma that are otherwise confined to 
the uterus. Sagawa et al33 compared peritoneal cytology pre- and 
posthysterosopy and concluded that hysteroscopy resulted in 12.5% of cases 
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having positive PWC. Sonada et al34 reported on 377 cases of Grade I/II 
endometrial carcinoma with no extrauterine spread. They found significantly 
more cases (independent of other prognostic factors) had positive PWC 
following laproscopic assisted vaginal hysterectomy (10%) than patients 
undergoing TAH (2.8%).  
 
Some authors have attempted to correlate the morphology of tumour cells 
identified in PWC with outcome. Yanoh et al35 concluded that cases with no 
evidence seeding and good outcome generally were less cellular; had less 
isolated cells and less groups with scalloped edges (Figure 8). Many of the 
cases that failed to develop macroscopic peritoneal disease showed sparse 
small 3-dimensional groups of cells with a morphology similar to that seen in 
endometrial carcinoma exfoliating and collected in Pap smears. A 
predominance of isolated cells in large numbers is also correlated with poor 
outcome in gastric36 and pancreatic31 carcinoma. 
 
Cervical Tumours 
PWC is of limited value for cervical carcinoma because peritoneal 
involvement generally occurs relatively late in the development of these 
tumours, with deep stromal and vascular involvement of more significance11. 
Mulvaney37 reported several cases of cervical carcinoma that were upstaged as 
a result of positive PWC, however these patients had nodal metastases and 
their treatment was not altered. Adenocarcinomas of the cervix are more likely 
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to yield positive PWC than squamous tumours37,38, as are recurrent cervical 
carcinoma cases3.  SCC is rarely identified in PW specimens and most 
commonly presents as poorly differentiated malignant cells38 . 
 
Less Common Tumours 
As well as carcinomas metastatic to the ovary, such as breast and colonic 
adenocarcinomas, fallopian tube cancer and primary peritoneal carcinoma are 
occasionally encountered in PWC. Serous papillary neoplasms may arise in the 
ovary, fallopian tube, endometrium and primary to the peritoneum. It is not 
easy to distinguish between the tumours on the basis of immunocytochemical 
profile39 or cytomorphology- all have in common the features of single cells 
and three dimensional groups of cells with round nuclei, single nucleoli, 
abundant, often vacuolated cytoplasm and sometimes psamomma bodies40.  
 
Non-Gynaecological Malignancies 
For gastric cancer, PWC provides clinically useful information. Positive PWC 
is associated with poor outcome for gastric cancer patients41,42. Patients with 
otherwise resectable gastric cancer and positive PWC have a survival 
comparable to stage IV tumours, even in the absence of macroscopic 
peritoneal disease and despite resection of all gross disease41,42.  
 
In pancreatic cancer, positive PWC is associated with advanced disease and 
may identify patients with occult peritoneal disease but is not an independent 
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risk factor31,43. Cases of long term survival, even with positive PWC have been 
reported and it is therefore not considered an indicator for non-resection31. For 
colonic cancer44 and cholangiocarcinoma45 positive PWC is not an 
independent prognostic indicator.  
 
Pitfalls 
Interpretive difficulties arise when a population of cells is present that appears 
different to the usual presentation of flat sheets of mesothelial cells. In addition 
to metastatic tumour, this may result from benign epithelium occurring in the 
peritoneum, such as Mullerian inclusions and fallopian tube epithelium, cells 
being spilt from ruptured cysts or due to reactive mesothelial changes. Benign 
reactive changes may be encountered in association with adhesion formation, 
pelvic inflammatory disease, endometriosis, ectopic pregnancy, adnexal 
infarction due to torsion, tubal abcess and hydrosalpinx. 
 
Mesothelial Cells 
Mesothelial cells, in all their various guises, pose the most common problems 
in PWC. In most cases the regular sheet-like arrangement of mesothelial cells 
that is characteristic of PWC makes their identification and discrimination 
from carcinoma easier than in effusion specimens where mesothelial cells are 
typically more rounded and the groupings more three dimensional. However 
large folded sheets of mesothelial cells in PW can sometimes mimic the 
papillary arrangements of carcinoma. Careful examination usually reveals the 
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flat, single-cell layering characteristic of benign mesothelial sheets. The often-
marked variation in nuclear size amongst different groups of mesothelial cells 
in the same preparation may also contribute to their misinterpretation. 
However the cohesiveness, regular spacing and local uniformity of nuclei are 
useful in correctly identifying their benign nature. 
 
Reactive mesothelial cells may be encountered in PW specimens, but more 
commonly in peritoneal effusions. They result of a wide variety of conditions, 
such as inflammatory conditions, endometriosis, ectopic pregnancy, tubo-
ovarian abcess, pelvic tumour, chemo- and radiotherapy and cirrhosis16,46,47. 
Tight clusters of mesothelial cells may mimic low grade and borderline 
tumours with smooth edged groups of cells with tightly packed nuclei and high 
N/C ratios (Figure 9). Identification of a predominantly monolayered 
arrangement (Figure 10), fine, even chromatin and a gradation of cellular 
change from cells with typical mesothelial characteristics to those with 
reactive features46 are helpful in recognising reactive change. Nevertheless, 
some cases demonstrate marked changes including prominent nucleoli and 
cells groups with considerable depth of focus and sometimes psammoma 
bodies. This can make discrimination from borderline and low grade tumours 
difficult (Figure 11). In some of these cases cell block preparations, 
immunocytochemistry or awaiting the results of surgical specimens are 
necessary to reliably identify the cell type. It should be emphasised that 
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psammoma bodies may be seen in a variety of benign conditions as well as 
borderline, invasive, and non-gynaecological tumours. 
 
Endometriosis 
The presence of endometrial glandular and stromal cells together with 
haemosiderophages is said to be diagnostic of endometriosis2. However 
endometrial cells and haemosiderophages are seen together in only about 30% 
of patients with laporoscopically confirmed endometriosis48. Haemosiderin-
laden macrophages alone are seen in about another third of patients with 
confirmed pelvic endometriosis. Although they are a non-specific finding that 
may be seen in any condition associated with leakage of blood into the 
peritoneum, in young patients lacking other causes for haemorrhage, 
haemosiderophages are highly suggestive of endometriosis48.  
 
Endometrial cells are difficult to reliably identify, as they may be similar in 
presentation to mesothelial cells or lymphoid cells48. Perhaps the most reliable 
method of identifying them is in cell block preparations where the epithelial 
and stromal elements may be seen6.  
 
The most common difficulty caused by endometriosis is the presence of 
reactive mesothelial cells2,3,16. These may form large aggregates (Figures 12 & 
13), sometimes with calcific concretions, mimicking serous tumours. 
Consideration of clinical history and observation of the mesothelial 
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characteristics of these groupings, such as limited depth of focus and 
uniformity of nuclear features and spacing, together with haemosiderophages 
are necessary to avoid false positive diagnoses. 
 
Endosalpingiosis 
Endosalpingiosis (Mullerian inclusions) is characterised by ectopic benign 
epithelium identical to fallopian tube epithelium. Endosalpingiosis is 
frequently multicentric, most commonly occuring in the pelvic peritoneum, 
lymph nodes and omentum and is thought to arise from a metaplastic process 
of the coelomic epithelum.  
 
It is a potential cause for false positive diagnoses3,49,50 as cytologically the 
cells from endosalpingioisis may present as tightly cohesive papillary 
fragments of cells that contrast with benign mesothelial cells. The cell 
aggregates are most commonly tubular or papillary and often surround 
psammoma bodies (Figures 14 & 15). Free psammoma bodies may be seen but 
single cells are usually lacking. Like reactive mesothelial cells, although the 
cells may have an increased N/C ratio and more prominent nucleoli, the 
epithelial groupings are usually single-layered with uniform, well spaced 
nuclei. In some cases cilia may be identified (Figure 16). The presence of more 
than mild to moderate nuclear atypia, complex branching architecture, single 
atypical cells or mitotic activity should weigh against a diagnosis of 
endosalpingiosis49,50 . 
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Cell Blocks and Special Stains 
Cell blocks provide a useful adjunct to cytological preparations of PWC6. 
They allow additional sampling of the specimen, assessment of 
microarchitecture and provide the optimal preparations for the performance of 
cytochemical and immunocytochemical (ICC) stains51. Cell blocks also 
provide a means for longer term ‘storage’ of material. 
 
Several studies have reported improvements in sensitivity for detection 
malignant cells in PWC in gastric52,53 and pancreatic54,55 cancer by using ICC 
to a range of carcinoma markers, including B72.3, CEA and CA 19-9. The 
same markers for metastatic carcinoma that are of value in effusion cytology 
are useful for PWC. These are best employed in a panel. The most useful of 
these markers include stains for CEA, B72.3, Ber Ep4, CD 15 and MOC-
3139,56. Identification of neutral mucin with PAS diastase staining is also 
useful. 
 
Calretinin is a useful marker for mesothelial cells57. A small proportion of 
carcinomas, such a poorly differentiated colonic adenocarcinomas, express 
calretinin, but most carcinomas are negative39,58,59. Even though the ovarian 
surface epithelium is calretinin positive, less than 10% of serous carcinomas 
are focally positive for calretinin39.  Wieczorek and Krane60 studied the value 
of calretinin in distinguishing serous borderline tumours from reactive 
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mesothelial cells and concluded that it was not useful. This was because of the 
frequent presence of admixed reactive mesothelial cells that will stain positive, 
and due to the variable staining of both borderline tumours and mesothelial 
cells. They reported that strips of benign mesothelial cells in PW specimens 
stain weakly or not at all for calretinin, whereas reactive and malignant 
mesothelial cells stain strongly. Serous tumours were usually negative but may 
show focal positivity with granular cytoplasmic staining, whereas mesothelial 
cells have nuclear and cytoplasmic staining, often more intense on the 
membrane, producing the characteristic ‘fried egg’ appearance61. Cytokeratin 
5/6 staining is another marker of mesothelial differentiation39 that appears 
more consistently expressed in normal mesothelial cells and is probably best 
used in a panel with calretinin and epithelial markers. 
 
Summary 
Detection of tumours in PWC relies on the identification of non-mesothelial 
arrangements and cells. High grade carcinoma is easily identified. However 
difficulties arise with groups of cells that are not of typical mesothelial nature, 
particularly when there is an absence of single cells or marked nuclear atypia 
but raised N/C ratio and small to prominent nucleoli (with or without 
psammoma bodies).  This raises the differential diagnosis of reactive 
mesothelial cells, endosalpingiosis, borderline serous tumour, low grade serous 
carcinoma. The morphology of these conditions shows considerable overlap 
and close attention to clinical history is essential. 
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Features favouring benign include: cilia, no single cells, few cells with 
cytoplasmic vacuolation, absence of mitotic activity and two distinct 
populations not identified. 
 
In cases with equivocal cytological findings correlation with surgical 
specimens is an essential step. 2,16,48,61 
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Figure 1. A sheet of benign mesothelial cells arranged in a 
mosaic pattern with distinct cytoplasmic borders. (Pap; 
x40 Obj) 
 
 
 
 
Figure 2. Sheet of mesothelial cells. Note that although 
variation in nuclear size is apparent throughout the sheet, 
nuclei are locally uniform. (Diff Quik; x20 Obj) 
 
 
 
 
 
Figure 3. Benign mesothelial cells with highly irregular 
nuclear membranes and longtitudinal nuclear grooves. 
(Pap; x40 Obj) 
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Figure 4. Collagen ball. Note the bland mesothelial 
cell nuclei arranged around a hyaline globule of 
collagen. (Pap; x40) 
 
 
 
 
 
 
Figure 5. A grouping of cells from an ovarian 
serous borderline tumour. Note the uniform 
hyperchromatic nuclei and high N/C ratio. (Pap; 
x20) 
 
 
 
 
Figure 6. Cell grouping from serous papillary 
carcinoma of ovary. Note irregular outline of 
group and cytoplasmic vacuolation. (Pap; x20) 
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Figure 7. Clear cell carcinoma of ovary. Note 
cells with abundant finely vacuolated cytoplasm 
surrounding metachromatic material. (Pap; x20 
Obj) 
 
 
 
 
Figure 8. Endometrial adenocarcinoma. 
Cohesive 3-dimensional grouping of cells with 
large cytoplasmic vacuoles. (Pap; x40 Obj) 
 
 
 
 
 
Figure 9. Reactive mesothelial cells with high 
N/C ratio but forming a monolayered sheet. 
(Pap, x40 Obj) 
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Figure 10. Sheet of reactive mesothelial cells. 
Note ‘windows’ between cells and monolayered 
arrangement. (Pap stain, x40 Obj) 
 
 
 
 
 
 
 
 
 
A      B 
Figure 11. Morphological similarity between low grade serous papillary 
carcinoma of ovary (A) and reactive mesothelial cells (B) from a benign 
inflammatory specimen. (both x20 Obj). 
 
 
 
Figure 12. Focus of peritoneal endometriosis with 
endometrial epithelial and stromal tissue and calcific 
concretions. (H&E, x10 Obj) 
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Figure 13. Peritoneal washing from the same 
patient as Fig 11, showing reactive mesothelial 
cells and haemosiderophages. (Pap, x40 Obj) 
 
 
 
 
 
Figure 14. Focus of endosalpingiois in a 
peritoneal biopsy. Note benign columnar 
epithelium and calcific concretions. (H&E, x10 
Obj) 
 
 
 
 
Figure 15. Peritoneal washing from the same case as 
Fig 14. Note large sheet of cells and psammoma 
bodies. (Pap stain, x40 Obj) 
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Figure 16. Ciliated epithelial cells in a peritoneal 
washing from a patient with endosalpingiosis. 
(Pap, x40 Obj). 
 
 
 
 
